Regeneron (REGN) Stock Price
$563.2 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Regeneron, AI stock picks, stock alerts and much more.
REGN AI Stock Analysis
AI stock analysis for REGN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron (REGN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Regeneron (REGN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron (REGN), currently trading at $563.2, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About REGN
-
Regeneron Pharmaceuticals, Inc.
-
Symbol
REGN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
60.2B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
REGN Alternative Data
Web Traffic
Regeneron receives an estimated 290550 monthly visitors to regeneron.com.
-
Web Traffic
290550
-
Change from Previous Month
1.1%
-
3 Month Change
15.8%
-
YoY Change
15.8%
News Mentions
Regeneron was mentioned 6 times in the news yesterday.
-
News Mentions
6
-
Daily Change
25%
-
1 Month Change
50%
-
3 Month Change
14.3%
Reddit Mentions
Regeneron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
Twitter Followers
Regeneron has 32,967 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
32967
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Facebook Engagement
Regeneron has engaged 744 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
744
-
Daily Change
7.4%
-
1 Month Change
54.7%
-
3 Month Change
406.1%
-
YoY Change
406.1%
Instagram Followers
Regeneron has 14,731 Instagram Followers on its main Instagram account, up by 2.6% over the last month.
-
Instagram Followers
14731
-
Daily Change
0%
-
1 Month Change
2.6%
-
3 Month Change
6.8%
-
YoY Change
6.8%
LinkedIn Followers
537,155 are following Regeneron on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
537155
-
Daily Change
0%
-
1 Month Change
1.8%
-
3 Month Change
5.4%
Job Postings
Regeneron has an estimated 297 open job postings, which is down -8.9% over the last month.
-
Job Postings
297
-
Daily Change
0.3%
-
1 Month Change
8.9%
-
3 Month Change
14.7%
-
YoY Change
14.7%
LinkedIn Employees
According to LinkedIn, Regeneron has 15,804 employees.
-
LinkedIn Employees
15804
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1%
-
YoY Change
1%
Business Outlook
According to employee reviews, the business outlook among employees at Regeneron is 81 out of 100 (very bullish).
-
Business Outlook
81
-
Change from Previous Month
1.2%
-
3 Month Change
0%
-
YoY Change
0%
REGN Financials
REGN Key Metrics
-
Total Revenue
$3.8B
-
Net Income
$917.7M
-
Earnings per Share
$8.53
-
Free cash flow
$995.8M
-
EBITDA
$1.1B
-
EBITDA Ratio
0.288979
-
Total Assets
$37.8B
REGN 2-year Revenue & Income
REGN 2-year Free Cash Flow
REGN Technicals
REGN SMA
REGN RSI
FAQ
What's the current price of Regeneron (REGN) Stock?
The price of an Regeneron (REGN) share is $563.2.
What's the market cap of Regeneron?
The current market cap of Regeneron is 60.2B.
Should I buy or sell REGN?
Regeneron shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Regeneron is better viewed as a hold or accumulate position while waiting for further developments.
Is Regeneron a good investment?
The current analysis of Regeneron's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Regeneron's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Regeneron (REGN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Regeneron stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Regeneron (REGN) that investors often compare it to?
Regeneron (REGN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Regeneron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron's stock price to be around $589.7 in 2026. Starting from the current price of $563.2, this represents a 4.7% change in price, indicating a neutral outlook for the stock.
How to buy Regeneron (REGN) Stock?
Regeneron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.